The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical varibles

Cellular and Molecular Biology Letters

Volumn 12, Issue 4, 2007, Pages 473-481

  Sankar, Srinivasagam Raja ^a   Manivasagam, Thamilarasan ^a   Krishnamurti, Arumugam ^a   Ramanathan, Manickam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidants; Behaviour; Midbrain; MPTP; TBARS; Withania somnifera

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CATALASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; WITHANIA SOMNIFERA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR; CHRONIC STRESS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; INTOXICATION; LIPID PEROXIDATION; MALE; MESENCEPHALON; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PLANT ROOT; WITHANIA SOMNIFERA;

MUS; WITHANIA SOMNIFERA;

EID: 38049153249     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-007-0015-0     Document Type: Article

References (37)

1. Agid, Y. Parkinson's disease: Pathophysiology Lancet 337 (1991) 1321-1324.
2. Tillerson, J.L. and Miller, G.W. Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism. J. Neurosci. Methods 123 (2003) 189-200.
3. Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H. and Hara, H. Rifampicin attenuates the MPTP induced neurotoxicity in mouse brain. Brain Res. 1082 (2006) 196-204.
4. Gao, Z.G., Cui, W.Y., Zhang H.T. and Liu, C.G. Effects of nicotine on 1-methyl,4-phenyl 1,2,3,6 tetrahydropyridine induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice. Pharmacol. Res. 38 (1998) 101-106.
5. Sindhu, M.K., Saravanan, K.S. and Mohanakumar K.P. Behavioral differences in a rotenone-induced hemiparkinsonism rat model developed following intranigral or median forebrain bundle infusion. Brain Res. 1051 (2005) 25-34.
6. Gerlach, M., Riederer, P., Przuntek, H. and Youdim, M.B.H. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208 (1991) 273-286.
7. Schmidt, N. and Ferger, B. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural Transm. 108 (2001) 1263-1282.
8. Rozas, G., Lopez-Martin, E., Guerra, M.J. and Labanderia-Garcia, J.L. The overall rod performance test in the MPTP-treated moue model of parkinsonism. J. Neurosci. Methods 83 (1998) 165-175.
9. Muralikrishnan, D., Samantarary, S. and Mohanakumar K.P. D-deprenyl protects nigrostriatal neurons against 1-methyl 4-phenbyl 1,2,3,6- tetrahyropyridine induced dopaminergic neurotoxicity. Synapse 50 (2003) 7-13.
10. Bhattacharya, S.K., Satyan, K.S., and Ghosal, S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J. Exp. Biol. 35 (1997) 236-239.
11. Panda, S. and Kar, A. Evidence for free radical scavenging activity of Ashwagandha root powder in mice. Indian J. Physiol. Pharmacol. 41 (1997) 424-426.
12. Raja Sankar, S., Manivasagam, T., Albert Singh, V., Krishnamurti, A. and Ramanathan, M. Prophylatic efficacy of Withania somnifera against MPTP-induced Parkinson's disease in mice. J. Cell Tissue Res. 7 (2007) 975-979.
13. Mohanasundari, M., Srinivasan, M.S., Sethupathy, S. and Sabesan, M. Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice. J. Neurol. Sci. 249 (2006) 140-144.
14. Fernagut, P.O., Diguet, E., Labattu, B. and Tison, F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods 113 (2002) 123-130.
15. Glowinski, J. and Iversen, L.L. Regional studies of cateholamines in the rat brain-I. J. Neurochem. 13 (1966) 655-669.
16. Fraga, C.G., Leibovitz, B.E. and Tappel, A.L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic. Biol. Med. 4 (1988) 155-161.
17. Kakkar, P., Das, B. and Viswanathan, P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21 (1984) 130-132.
18. Sinha, A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394.
19. Lowry, O.H., Rosebrough, N.J., Farr A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
20. Shimazu, S., Takahata, K., Tamashiro, A., Yoneda, F., Iida, Y. and Saji, H., Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine and diethyldithiocarbamate. J. Neural Transm. 110 (2003) 871-883.
21. Hanakawa, T., Katsumi, Y., Fukuyuma, H., Honda, M., Hayashi, T., Kimura, J. and Shibasaki, H. Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain 122 (1999) 1271-1282.
22. Ahmad, M., Saleem, S., Ahmad, A.S., Ansari, M.A., Yousuf, S., Hoda, M.N. and Islam, F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Human. Exp. Toxicol. 24 (2005) 137-147.
23. Dhanasekaran, M., Uthayathas, S., Karuppagounder, S.S., Parameshwaran, K., Suppiramaniam, V., Ebadi, M. and Brown-Borg, H.M. Ebselen effects on MPTP-induced neurotoxicity. Brain Res. 1118 (2006) 251-254.
24. Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. and Marsden, C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 (1989) 381-389.
25. Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, C.D. Increased levels of lipid hydroperoxides in the parkinsonia substania nigra: an HPLC and ESR study. Mov. Disord. 9 (1994) 92-97.
26. Chiba, K., Trevor, A. and Castagnoli, N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120 (1984) 574-578.
27. Zang, L.Y. and Misra, H.P. Generation of reactive oxygen species during the monoamine oxidase catalysed oxidation of the neurotoxicant 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine. J. Biol. Chem. 268 (1993) 16504-16512.
28. Rojas, P. and Rios, C. Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Pharmacol Toxicol. 72 (1993) 364-368.
29. Adams, J.D. Jr., Klaidman, L.K. and Leung A.C. MPP+ and MPDP+ induced oxygen radical formation with mitchondrial enzymes. Free Radic. Biol. Med. 15 (1993) 181-186.
30. Muralikrishnan, D. and Mohanakumar, K.P. Neuroprtotection by bromocriptine against 1-methy1 4-pheny1 1,2,3,6 tetrahydrophyridine induced neurotoxicity in mice. FASEB J. 12 (1998) 905-912
31. Rajeswari, A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur. Rev. Med. Pharmacol. Sci. 10 (2006) 157-161.
32. Devi, P.U., Sharada, A.C., Solomon, F.E. and Kamath, M.S. In vivo growth inhibitory effect of Withania somnifera on a transplantable mouse tumor, Sarcoma 180. Indian J. Exp. Biol. 30 (1992) 169-172.
33. Dhuley, J.N. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J. Ethnopharmacol. 70 (2000) 57-63.
34. Russo, A., Izzo A.A., Cardile, V., Borrelli, F. and Vanella, A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 8 (2001) 125-132.
35. Bhattacharya, S.K., Kumar, A. and Ghosal, S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Phytother. Res. 9 (1995)110-113.
36. Andallu, B. and Radhika, B. Hypoglycemic, and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J. Exp. Biol. 38 (2000) 607-609.
37. Dhuley, J.N. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother. Res. 15 (2001) 524-528.